Literature DB >> 12963914

Expression of peroxiredoxin II in vascular tumors of the skin: a novel vascular marker of endothelial cells.

Seung-Chul Lee1, Yong-Pil Na, Jee-Bum Lee.   

Abstract

BACKGROUND: The peroxiredoxin (Prx) family consists of peroxidases to remove H(2)O(2) by using the thioredoxin system. In a previous study, Prx II was ubiquitously expressed in the epidermis and dermis including dermal vessels.
OBJECTIVE: This study aims to elucidate expression patterns of Prx II in benign and malignant vascular tumors.
METHODS: Immunohistochemical staining for Prx II, factor VIII-related antigen, and CD34 was performed in formalin-fixed specimens.
RESULTS: Prx II was strongly expressed in mature endothelial cells of benign vascular tumors, whereas it was expressed weakly or not expressed in immature endothelial cells in malignant tumors of Kaposi's sarcoma and angiosarcoma. The expression patterns of Prx II were similar to those of factor VIII-related antigen, rather than CD34.
CONCLUSIONS: Prx II can be used as a novel marker of endothelial cells and indicates that reactive oxygen may play a role in the pathogenesis of vascular tumors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12963914     DOI: 10.1067/s0190-9622(03)01485-3

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  9 in total

Review 1.  Redox balance dynamically regulates vascular growth and remodeling.

Authors:  Shyamal C Bir; Gopi K Kolluru; Kai Fang; Christopher G Kevil
Journal:  Semin Cell Dev Biol       Date:  2012-05-24       Impact factor: 7.727

2.  Identification of differentially expressed genes in cutaneous squamous cell carcinoma by microarray expression profiling.

Authors:  Ingo Nindl; Chantip Dang; Tobias Forschner; Ralf J Kuban; Thomas Meyer; Wolfram Sterry; Eggert Stockfleth
Journal:  Mol Cancer       Date:  2006-08-08       Impact factor: 27.401

3.  Vasculitis induced by immunization with Bacillus Calmette-Guérin followed by atypical mycobacterium antigen: a new mouse model for Kawasaki disease.

Authors:  Tsuneyuki Nakamura; Jun-Ichi Yamamura; Hitoshi Sato; Hiroaki Kakinuma; Hiroaki Takahashi
Journal:  FEMS Immunol Med Microbiol       Date:  2007-02-12

4.  The immunohistochemical detection of peroxiredoxin 1 and 2 in canine spontaneous vascular endothelial tumors.

Authors:  Narumi Otsuka; Kairi Ishimaru; Mami Murakami; Minami Goto; Akihiro Hirata; Hiroki Sakai
Journal:  J Vet Med Sci       Date:  2022-05-19       Impact factor: 1.105

5.  Selectively decreased expression of peroxiredoxins induced by silica in pulmonary epithelial cells.

Authors:  Hye Lim Lee; Young Sun Kim; Joo Hun Park; Wou Young Chung; Kyu Sung Lee; Yoon Jung Oh; Seung Soo Sheen; Kwang Joo Park; Sung Chul Hwang
Journal:  Korean J Intern Med       Date:  2009-08-26       Impact factor: 2.884

6.  Vascular endothelial growth factor-D modulates oxidant-antioxidant balance of human vascular endothelial cells.

Authors:  Izabela Papiewska-Pająk; Aneta Balcerczyk; Emilia Stec-Martyna; Wiktor Koziołkiewicz; Joanna Boncela
Journal:  J Cell Mol Med       Date:  2016-12-13       Impact factor: 5.310

7.  Proteomic analysis of ovomucoid hypersensitivity in mice by two-dimensional difference gel electrophoresis (2D-DIGE).

Authors:  D J Hobson; P Rupa; G J Diaz; H Zhang; M Yang; Y Mine; P V Turner; G M Kirby
Journal:  Food Chem Toxicol       Date:  2007-08-23       Impact factor: 6.023

Review 8.  The function of the co-chaperone ERdj4 in diverse (patho-)physiological conditions.

Authors:  Lea Daverkausen-Fischer; Felicitas Pröls
Journal:  Cell Mol Life Sci       Date:  2021-12-24       Impact factor: 9.261

9.  Genome-Wide Selective Signatures Reveal Candidate Genes Associated with Hair Follicle Development and Wool Shedding in Sheep.

Authors:  Zhihui Lei; Weibo Sun; Tingting Guo; Jianye Li; Shaohua Zhu; Zengkui Lu; Guoyan Qiao; Mei Han; Hongchang Zhao; Bohui Yang; Liping Zhang; Jianbin Liu; Chao Yuan; Yaojing Yue
Journal:  Genes (Basel)       Date:  2021-11-29       Impact factor: 4.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.